Terazosin 10 mg Capsules is included in the Pill Pass Discount Drug List at Pill Pals Pharmacy. This educational article summarizes key FDA-label topics for patients, caregivers, and prescribers who want a plain-language overview before speaking with a physician or pharmacist.
Drug Name
Terazosin 10 mg Capsules
FDA Labeled Indications
Terazosin is FDA-labeled for hypertension and for signs and symptoms of benign prostatic hyperplasia.
Contraindications
Contraindications include hypersensitivity to terazosin.
Warnings
Warnings include marked low blood pressure, first-dose syncope, dizziness, fainting, priapism, and intraoperative floppy iris syndrome.
Precautions
Dose titration and bedtime dosing may reduce first-dose effects. Use caution with other blood pressure medicines, PDE-5 inhibitors, older age, and activities requiring alertness.
Adverse Reactions
Adverse reactions may include dizziness, weakness, headache, drowsiness, nasal congestion, swelling, palpitations, and low blood pressure.
Pill Pass Discount Drug List Notes
Availability, quantity limits, manufacturer selection, and final dispensing decisions may depend on prescription requirements, clinical appropriateness, inventory, and applicable law. This article is informational and is not a substitute for individualized medical advice, diagnosis, treatment, or the full FDA-approved labeling for the dispensed product.
Related Pill Pass Discount Drug List Articles
For related medications on the same Pill Pass Discount Drug List, you may also review Terazosin 1 mg Capsules, Terazosin 2 mg Capsules, Terazosin 5 mg Capsules, and Tizanidine 2 mg Capsules.
Source note: this article is written as a patient-friendly summary of FDA labeling topics available through DailyMed and related FDA labeling resources. Manufacturer-specific labeling can vary, so patients should rely on the medication guide, package insert, prescriber instructions, and pharmacist counseling for their specific product.
Terazosin 10 mg Capsules is on the Pill Pass List. This information is accurate as of May 13, 2026. If you would like more information on this medication, please contact your Physician or Pharmacist.
